Impact of COVID-19 on Product Procurement and Production Activities
First written in FY2020. 4 of 5 entries say "Restated". Latest entry: FY2025-H1.
The whole theme swung hardest in 2025: 5 of 16 companies on the "Worse" side.
19 other companies' latest entry also says "Restated".
- FY2025-H1RestatedAnnual report
「No new business or other risks arose during the current interim consolidated accounting period. In addition, there were no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The company has disclosed that there have been no material changes in the impact of COVID-19 on product procurement and production activities. - FY2024-Q3RestatedAnnual report
「No new business or other risks arose during the cumulative third quarter of the current consolidated fiscal year. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The company has disclosed that there have been no material changes in the impact of COVID-19 on product procurement and production activities. - FY2022RestatedAnnual report
「With regard to supply chain risks, we are working to mitigate those risks by increasing inventory as appropriate and establishing a system that enables alternative production in Japan.」
The risk of supply shortages caused by lockdowns and other factors affecting overseas business partners was reiterated, and measures involving increased inventory and alternative domestic production remain in place. - FY2021-Q2RestatedAnnual report
「No new business or other risks arose during the six-month period ended [the second quarter]. There were also no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company has disclosed that there have been no material changes in the impact of COVID-19 on product procurement and production activities. - FY2020First statedAnnual report
「In addition, our domestic production facilities for our own products have continued to operate as usual, while the operating rates of our contract manufacturers overseas, in the Philippines and Malaysia, have declined due to the impact of lockdowns and other factors. As of now, we hold a certain level of product inventory, and have temporarily begun producing some products with low inventory levels at our domestic factories as an alternative. As a result, there has been no significant disruption to product supplies.」
Although overseas contract manufacturers have in fact experienced lower operating rates, the filing states that there was no significant disruption to supplies as of the filing date, owing to secured inventory and alternative production at domestic factories.